| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,104 |
33,880 |
$1.45M |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,503 |
3,445 |
$216K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,704 |
2,672 |
$170K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,765 |
3,535 |
$166K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,615 |
1,604 |
$111K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,457 |
2,307 |
$94K |
| 93000 |
|
5,137 |
5,007 |
$56K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,970 |
7,132 |
$52K |
| 90674 |
|
2,413 |
2,391 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,447 |
1,331 |
$47K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,610 |
1,464 |
$35K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,623 |
2,601 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
16,366 |
15,988 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,217 |
952 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
177 |
166 |
$15K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,639 |
1,563 |
$10K |
| 93922 |
|
557 |
528 |
$8K |
| 99349 |
|
148 |
120 |
$6K |
| 90688 |
|
374 |
374 |
$6K |
| 99397 |
|
203 |
199 |
$4K |
| 96127 |
|
1,853 |
1,612 |
$4K |
| 90661 |
|
208 |
199 |
$4K |
| 99490 |
Ccm add 20min |
2,871 |
2,653 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
414 |
350 |
$2K |
| 81002 |
|
2,337 |
2,250 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,165 |
1,006 |
$1K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
417 |
398 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
106 |
103 |
$792.67 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
309 |
173 |
$792.44 |
| 99343 |
|
20 |
20 |
$564.33 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$537.94 |
| 90694 |
|
89 |
84 |
$340.69 |
| 99457 |
|
442 |
400 |
$270.31 |
| G0008 |
Administration of influenza virus vaccine |
575 |
537 |
$252.63 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
16 |
$227.03 |
| 99497 |
|
69 |
56 |
$220.75 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
177 |
123 |
$211.99 |
| 99454 |
|
429 |
381 |
$109.68 |
| 81025 |
|
26 |
25 |
$86.02 |
| 88150 |
|
12 |
12 |
$78.74 |
| 3078F |
|
4,130 |
3,818 |
$9.00 |
| 99453 |
|
49 |
42 |
$8.72 |
| 3075F |
|
1,754 |
1,647 |
$5.00 |
| 3074F |
|
3,783 |
3,488 |
$5.00 |
| 3044F |
|
1,872 |
1,778 |
$3.00 |
| 3079F |
|
1,482 |
1,385 |
$2.00 |
| 1160F |
|
391 |
376 |
$0.00 |
| 3077F |
|
123 |
114 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,596 |
2,482 |
$0.00 |
| 3288F |
|
452 |
426 |
$0.00 |
| 1159F |
|
392 |
377 |
$0.00 |
| 90653 |
|
30 |
30 |
$0.00 |
| 3046F |
|
52 |
49 |
$0.00 |
| 3051F |
|
64 |
64 |
$0.00 |
| 1126F |
|
506 |
471 |
$0.00 |
| 1123F |
|
523 |
484 |
$0.00 |
| 3017F |
|
345 |
337 |
$0.00 |
| 1170F |
|
442 |
426 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
15 |
15 |
$0.00 |